Correlation Between SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCANSOURCE and Hisamitsu Pharmaceutical Co, you can compare the effects of market volatilities on SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCANSOURCE (SC3SG) with a short position of Hisamitsu Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical.

Diversification Opportunities for SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical

0.24

Correlation Coefficient

SCANSOURCE (SC3SG)  Hisamitsu Pharmaceutical

Modest diversification

The 3 months correlation between SCANSOURCE and Hisamitsu is 0.24. Overlapping area represents the amount of risk that can be diversified away by holding SCANSOURCE and Hisamitsu Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hisamitsu Pharmaceutical and SCANSOURCE (SC3SG) is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCANSOURCE are associated (or correlated) with Hisamitsu Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hisamitsu Pharmaceutical has no effect on the direction of SCANSOURCE (SC3SG) i.e., SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical go up and down completely randomly.

Pair Corralation between SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical

Assuming the 90 days trading horizon SCANSOURCE is expected to generate 1.23 times more return on investment than Hisamitsu Pharmaceutical. However, SCANSOURCE (SC3SG) is 1.23 times more volatile than Hisamitsu Pharmaceutical Co. It trades about 0.07 of its potential returns per unit of risk. Hisamitsu Pharmaceutical Co is currently generating about 0.02 per unit of risk. If you would invest  2,660  in SCANSOURCE on October 4, 2024 and sell it today you would earn a total of  1,860  from holding SCANSOURCE or generate 69.92% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

SCANSOURCE  vs.  Hisamitsu Pharmaceutical Co

SCANSOURCE (SC3SG)

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in SCANSOURCE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, SCANSOURCE (SC3SG) may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Hisamitsu Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hisamitsu Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Hisamitsu Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical

The main advantage of trading using opposite SCANSOURCE (SC3SG) and Hisamitsu Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCANSOURCE (SC3SG) position performs unexpectedly, Hisamitsu Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hisamitsu Pharmaceutical will offset losses from the drop in Hisamitsu Pharmaceutical's long position.

The idea behind SCANSOURCE and Hisamitsu Pharmaceutical Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.